ReviewTaiwan journal of ophthalmology
Anatomical, functional outcomes, and complications of human amniotic membrane graft for macular hole: A systematic review.
Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Standard surgical management of macular hole (MH) has its own limitations due to the broad spectrum and subtypes of the pathology itself. Human amniotic membrane (hAM) grafts have been proposed as one of the promising alternatives to the standard protocol. We conducted a systematic review to assess the anatomical, functional outcomes, and complication of the utilization of hAM grafts in the treatment of variety of MH. We searched for studies published in Pubmed, ScienceDirect, Proquest, and Cochrane databases. We included studies which reporting the use of hAM for the treatment of MH with the outcomes are MH closure, visual acuity improvement, and complications/adverse events. A total of 18 studies on 221 eyes were included in this study. In all studies, the MH closure rate was 100% in primary MH, 91% in persistent/refractory MH, 92% in high myopia (HM), 95% in retinal detachment (RD), and 100% in large MH subgroup. The VA improvement rate was 86% in primary MH subgroup, and 66% in persistent/refractory MH subgroup, 77% in HM-MH subgroup, 93% in MH-RD subgroup, and 64% in large MH subgroup. Only seven cases of complications reported in this systematic review. Transplantation of hAM plug as treatment for various MH cases results in favorable anatomical and functional outcomes. Additionally, using hAM demonstrates a low incidence of postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.